XTX Topco Ltd purchased a new position in shares of Enovix Co. (NASDAQ:ENVX – Free Report) in the second quarter, HoldingsChannel reports. The institutional investor purchased 53,064 shares of the company’s stock, valued at approximately $820,000.
A number of other large investors also recently modified their holdings of the business. Arizona State Retirement System lifted its holdings in shares of Enovix by 2.3% during the second quarter. Arizona State Retirement System now owns 40,097 shares of the company’s stock worth $620,000 after buying an additional 905 shares during the last quarter. Corient Private Wealth LLC raised its stake in shares of Enovix by 1.9% in the fourth quarter. Corient Private Wealth LLC now owns 49,587 shares of the company’s stock valued at $621,000 after purchasing an additional 910 shares in the last quarter. Blue Trust Inc. raised its stake in shares of Enovix by 102.1% in the second quarter. Blue Trust Inc. now owns 1,894 shares of the company’s stock valued at $29,000 after purchasing an additional 957 shares in the last quarter. Voisard Asset Management Group Inc. raised its stake in shares of Enovix by 25.0% in the second quarter. Voisard Asset Management Group Inc. now owns 5,000 shares of the company’s stock valued at $77,000 after purchasing an additional 1,000 shares in the last quarter. Finally, Principal Financial Group Inc. raised its stake in shares of Enovix by 7.7% in the second quarter. Principal Financial Group Inc. now owns 20,079 shares of the company’s stock valued at $310,000 after purchasing an additional 1,434 shares in the last quarter. 50.92% of the stock is currently owned by institutional investors and hedge funds.
Enovix Price Performance
Shares of ENVX stock opened at $8.45 on Monday. The stock’s fifty day moving average is $11.33 and its 200-day moving average is $10.52. The company has a debt-to-equity ratio of 0.97, a quick ratio of 3.84 and a current ratio of 3.98. The stock has a market capitalization of $1.44 billion, a PE ratio of -6.31 and a beta of 1.99. Enovix Co. has a 52 week low of $5.70 and a 52 week high of $18.68.
Analysts Set New Price Targets
A number of research analysts recently commented on the company. Canaccord Genuity Group upped their target price on Enovix from $17.00 to $20.00 and gave the company a “buy” rating in a research note on Thursday, August 1st. Cantor Fitzgerald restated an “overweight” rating and issued a $30.00 target price on shares of Enovix in a research note on Thursday, August 1st. TD Cowen upped their target price on Enovix from $11.00 to $14.00 and gave the company a “hold” rating in a research note on Thursday, August 1st. Benchmark started coverage on Enovix in a research report on Monday, July 22nd. They issued a “buy” rating and a $25.00 price target on the stock. Finally, B. Riley upgraded Enovix to a “strong-buy” rating in a research report on Tuesday, June 25th. One research analyst has rated the stock with a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, Enovix currently has an average rating of “Buy” and a consensus target price of $21.33.
Read Our Latest Analysis on ENVX
About Enovix
Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.
Featured Stories
- Five stocks we like better than Enovix
- Stock Dividend Cuts Happen Are You Ready?
- 3 Stocks That Could Rise on European Bank Interest Rate Cuts
- Health Care Stocks Explained: Why You Might Want to Invest
- Take Advantage of Village Farms Stock as Cannabis Market Evolves
- What Are Dividend Achievers? An Introduction
- MarketBeat Week in Review – 9/16 – 9/20
Want to see what other hedge funds are holding ENVX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Enovix Co. (NASDAQ:ENVX – Free Report).
Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.